Equity Overview
Price & Market Data
Price: $1.23
Daily Change: -$0.01 / 0.81%
Range: $1.18 - $1.26
Market Cap: $33,394,500
Volume: 103,846
Performance Metrics
1 Week: -0.81%
1 Month: -19.08%
3 Months: 6.96%
6 Months: -4.65%
1 Year: -7.52%
YTD: 11.82%
Company Details
Employees: 71
Sector: Electronic technology
Industry: Electronic equipment/Instruments
Country: United States
Details
Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company offers FemaSeed, an intratubal insemination solution; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; FemCath, a cornual balloon catheter for selective fallopian tube evaluation; and FemChec, a controlled contrast-generating device for fallopian tube diagnosis. Its product candidate, FemBloc, is a non-surgical permanent birth control solution. It offers its products to reproductive endocrinologists for infertility products, gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.